Omalizumab for chronic spontaneous urticaria: a boon for sufferers, but there are unanswered questions.
Cutaneous Allergy Clinic, St John's Institute of Dermatology, St Thomas' Hospital, London, SE1 7EH, U.K. mwatsong@hotmail.com.
M W
MW
Greaves
D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D006801:Humans; D000069444:Omalizumab / Q000627:therapeutic use*; D014581:Urticaria / Q000188:drug therapy*
D018926:Anti-Allergic Agents; D000069444:Omalizumab